Wealthcare Advisory Partners’s MacroGenics MGNX Stock Holding History

Wealthcare Advisory Partners’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-685	Closed	-$4K	–	947
2020 Q1	$4K	Hold	685	–	–	﹤0.01%	1164
2019 Q4	$7K	Hold	685	–	–	﹤0.01%	1036
2019 Q3	$9K	Hold	685	–	–	﹤0.01%	947
2019 Q2	$12K	Hold	685	–	–	﹤0.01%	864
2019 Q1	$12K	Hold	685	–	–	﹤0.01%	776
2018 Q4	$9K	Hold	685	–	–	﹤0.01%	812
2018 Q3	$15K	Hold	685	–	–	﹤0.01%	752
2018 Q2	$14K	Hold	685	–	–	﹤0.01%	751
2018 Q1	$17K	Hold	685	–	–	﹤0.01%	624
2017 Q4	$13K	Hold	685	–	–	﹤0.01%	614
2017 Q3	$13K	Buy	+685	New	+$11.9K	﹤0.01%	497

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wealthcare Advisory Partners's MGNX Position: Q2 2020 in Review

Wealthcare Advisory Partners sold out of MacroGenics (MGNX) in Q2 2020, closing a stake of 685 shares — an estimated $4K sold.

Wealthcare Advisory Partners first reported a position in MGNX in Q3 2017 and held it in 11 quarters. The position peaked at $17K in Q1 2018. 137 funds tracked by Wall St. Rank hold MGNX as of Q2 2020.

Wealthcare Advisory Partners reported no remaining MacroGenics position as of Q2 2020 after selling out during the quarter.
Wealthcare Advisory Partners sold 685 MacroGenics shares in Q2 2020, an estimated $4K.
Wealthcare Advisory Partners first reported a position in MacroGenics in Q3 2017 and held it in 11 quarters.
Wealthcare Advisory Partners's MacroGenics position peaked at $17K in Q1 2018.
137 funds tracked by Wall St. Rank held MacroGenics as of Q2 2020.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2020, filed 29 Jul 2020.